| 000 | 019070000a22003490004500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 005 | 20250223024955.0 | ||
| 008 | 070715s2006 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC |
||
| 041 | 0 | _aEng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.19.01.Ph.D.2006.Kh.C | ||
| 100 | 0 | _aKhaled Gamil Ibrahim | |
| 245 | 1 | 0 |
_aContinuous epidural infusion of midazolam for postoperative analgesia in major pelvic surgery : _bComparative study with ropivacaine / _cKhaled Gamil Ibrahim ; Supervised AbdElfattah AbdElsattar , Mohamed Tarek Mansour , Mohamed Elhag , Elgohary Moussa |
| 246 | 1 | 5 |
_aالحقن المستمر لعقار الميدازولام خارج الام الجافية لازالة الام ما بعد الجراحة فى عمليات الحوض الكبرى : _bدراسة مقارنة لعقار الروبيفيكين |
| 260 |
_aCairo : _bKhaled Gamil Ibrahim , _c2006 |
||
| 300 |
_a147P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - National Cancer Institute - Department Of Anaesthesia and Pain Relief | ||
| 520 | _aThe study was conducted on "60" patients who underwent radical cystectomy , hysterectomy , or resection of lower gasterointestinal tumors.postoperative analgesia was managed by continuous epidural infusion of ropivacaine 0.2 (Group R) , midazolam 0.02 (Group M) or a combination of ropivacaine 0.2 + midazolam 0.02 (Group R M) in a total infusion rate of 5ml / hour for 48 hours | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aEpidural | |
| 653 | 4 | _aMidazolam | |
| 653 | 4 | _aRopivacaine | |
| 700 | 0 |
_aAbdElfattah AbdElsattar , _eSupervisor |
|
| 700 | 0 |
_aMohamed Elhag , Elgohary Moussa , _eSupervisor |
|
| 700 | 0 |
_aMohamed Tarek Mansour , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aMustafa _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c2956 _d2956 |
||